Advisory Research’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-19,911
Closed -$1.04M 413
2021
Q2
$1.04M Sell
19,911
-10,822
-35% -$617K 0.07% 203
2021
Q1
$1.71M Sell
30,733
-11,388
-27% -$515K 0.12% 142
2020
Q4
$1.3M Buy
+42,121
New +$1M 0.1% 165

Other funds holding VCEL

Advisory Research's VCEL Position: Q3 2021 in Review

Advisory Research sold out of Vericel Corp (VCEL) in Q3 2021, closing a stake of 19,911 shares — an estimated $1.04M sold.

Advisory Research first reported a position in VCEL in Q4 2020 and held it in 3 quarters. The position peaked at $1.71M in Q1 2021. 202 funds tracked by Wall St. Rank hold VCEL as of Q3 2021.

  • Advisory Research reported no remaining Vericel Corp position as of Q3 2021 after selling out during the quarter.
  • Advisory Research sold 19,911 Vericel Corp shares in Q3 2021, an estimated $1.04M.
  • Advisory Research first reported a position in Vericel Corp in Q4 2020 and held it in 3 quarters.
  • Advisory Research's Vericel Corp position peaked at $1.71M in Q1 2021.
  • 202 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2021.

Based on Advisory Research's 13F filing for Q3 2021, filed 12 Nov 2021.